Update on radiotherapy-related early adverse effects and quality of life in prostate cancer patients of the prospective REQUITE study
Seibold, P.; Talbot, C.; Vega, A.; West, C.; Rancati, T.; Chang-Claude, J. · Das Gesundheitswesen · 2017 · Heft 8/09 · S. 1 bis 1
Bibliografische Angaben
Zusammenfassung
Introduction: We previously assessed treatment adverse effects (AEs) and worsening of quality of life (QoL) in 480 prostate cancer patients undergoing radiotherapy (RT) recruited for the REQUITE study. We now report on an updated analysis in the final REQUITE prostate cohort. Methods: Prostate cancer patients undergoing RT (N = 1, 811) were recruited in eight countries between 04/2014 – 09/2016 for a multi-centre prospective cohort study (www. requite. eu). Global Health Status/QoL was assessed using EORTC/QLQ-C30. Early AEs (gastrointestinal/GI, genitourinary/GU) were physician-scored using CTCAE v4. 0. We excl…